New York, New York-based Bristol-Myers Squibb Company BMY released financial results on Thursday morning.
Bristol-Myers Squibb Company announced that its 4th quarter net earnings from continuing operations fell to $483 million, or 28 cents per share, down from $818 million, or 41 cents per share, a year earlier.
Excluding special items, the company reported earnings of 47 cents per share.
Bristol-Myers Squibb Company reported revenue of $5.11 billion, up 2% from $5.03 billion a year earlier.
According to a poll of analysts by Thomson Reuters, the average Wall Street estimate called for earnings of 47 cents per share, on revenue of $5.05 billion.
Bristol-Myers Squibb Company (BMY) finished the previous trading day at $25.93 per share. The consensus price target of analysts covering the company's stock is $26.79 per share.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in